3Black RL, Oglesby RB, von Sallman L, et al. Posterior subcapsular cataracts induced by corticoids in patients with rheumatoid arthritis. JAMA, 1960,174: 166-171.
4Derby L, Maier WC. Risk of cataract among users of intranasal corticosteroids. J Allergy Clin Immunol. , 2000,105: 912-916.
5Bettmann JW, Fund WE, Webster RG, et al. Cataractogenic effect of corticosteroids on animals. Am J Ophthalmol, 1967,63:841-844.
6Kivilcim M, Peyman GA, E1-Dessouky ES, et al. Retinal toxicity of triamcinolone acetonide in silicone-filled eyes. Ophthalmic Surg Lasers, 2000,31: 474-478.
7Gillies M, Simpson JM, Billson FA, et al. Safety of an intravitreal injection of triamcinolone. results from a randomized clinical trial. Arch Ophthalmol , 2004,22: 336-340.
8Mccuun BW, Bessler M, Tano Y, et al. The lack of toxicity of intravitreally administered triamcinolone acetonide. Am J Ophthalmol , 1981,91: 785-788.
9Gopal L, Bhende M, Sharma T. Vitrectomy for accidental intraocular steroid injection. Retina, 1995,15: 295-299.
10Enaida H, Sakamoto T, Ueno A, et al. Submacular deposition of triamcinolone acetonide after triamcinolone-assisted vitrectomy.Am J Ophthalmol , 2003,135:243-246.
3Magalhaes 0 Jr, Maia M, Rodrigues EB, et al. Perspective on fluid and solid dynamics in different pars plana vitrec- tomy systems [J]. Am J Ophthalmol , 2011,151 : 401 - 405.
